Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04768569 · ClinicalTrials.gov registry record · Phase 2
Noise-Induced Hearing Loss-Acute Exposure Treatment
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT04768569 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 24 participants.
The verdict
NCT04768569, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of zonisamide for the treatment of noise-induced hearing loss in adults.
Interventions
- DRUG Placebo
- DRUG Zonisamide 100Mg Cap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-10-04 |
| Est. Completion | 2023-09-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04768569
The ClinicalTrials.gov registry entry for NCT04768569 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04768569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04768569 about?
NCT04768569 is a clinical study titled "Noise-Induced Hearing Loss-Acute Exposure Treatment". The purpose of this study is to assess the safety and efficacy of zonisamide for the treatment of noise-induced hearing loss in adults.
What is the current status of trial NCT04768569?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2021-10-04. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT04768569?
The interventions under investigation include: Placebo (DRUG), Zonisamide 100Mg Cap (DRUG).
Who is sponsoring clinical trial NCT04768569?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.